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Case Study 
Introduction:  
Steven-Johnson’s Syndrome (SJS) and 
Toxic Epidermal Necrolysis (TEN) are 
both diseases mediated by 
hypersensitive immune reactions 
resulting in “full thickness epidermal 
necrosis” characterized by skin 
detachment. However, in SJS, there is 
only 10% skin surface area involvement 
whereas in TEN, over 30% of the skin 
becomes detached. TENS has a 50% 
mortality rate. (East-Innis & Thompson, 
2013, p. 590) 
 
Why Chosen: SJS/TEN is a rare but 
extremely fatal disease. Initially, it is 
often mistaken as a simple allergic 
reaction to a new medication or 
environmental exposure because both 
cause truncal rashes and fevers. 
However, simple allergic reactions occur 
within days of exposure versus SJS/TEN, 
which will not mount signs and 
symptoms until one to three weeks after 
initial exposure; Meaning it is a delayed 
hypersensitivity reaction. (Cooper, 2012, 
p. 54) 
 
Presentation of Case:  
Day 1: Patient (pt) is a 56-year-old black 
female with a history of Chronic 
Obstructive Pulmonary Disorder 
(COPD), Diabetes Mellitus, Type II, and 
Hyptertension presents to the hospital 
with Community-Aquired Pneumonia 
(CAP) versus Acute Exacerbation of 
COPD. Her vital signs are stable (VSS0. 
Her White Blood Cell (WBC) count 
14,000x109/L. The patient was  placed 
on intravenous Vancomycin-Hcl for 
broad-spectrum coverage against 
suspected CAP. 
Day 8: Lesions and hemmorhagic 
crusting begin to form around her 
mouth. Anus appears swollen. VSS.  
Day 9: Truncal blister and papules begin 
to form over entire trunk, pt’s pain in 
mouth, anus and trunk 6/10. Heart Rate 
(HR) 110 Sinus Rhythm, 
WBC18,000x109/L, Respiratory Rate 
(RR) 24. Vancomycin discontinued due 
to suspected drug allergy. 
Day 10, 05:00am: Blisters have erupted 
over trunk and mouth, draining 
serosanguinous fluid, cultures sent, 
fissures emerging, HR 140 Atrial 
fibrillation with Rapid Ventricular 
Response, BP 96/40, RR 30, 
WBC24,000x109/L. Pt intubated for 
Respiratory Failure, given 5L NS bolus, 
and started on Levophed at 15mcg/min.  
 
 
 
 
 
 
Pathophysiology Treatment 
        Remove offending medication 
Immediately. Supportive care might 
include air-fluidized beds to prevent 
deep tissue injury, hydrogel dressings to 
minimize epidermal damage, ventilatory 
support, nutritional support to optimize  
wound healing, IV fluid replacement and  
plasmapheresis to hasten the removal of  
the offending medication from the body.  
Immunosuppressive drugs such as  
corticosteroids are now under  
investigation to determine validity.  
(Cooper, 2012, p. 55) 
        In conclusion, SJS/TEN is a severely 
debilitating, potentially fatal  
hypersensitivity reaction that requires  
vigilant supervision and delicate  
treatment. If caught early, chances of  
survival markedly improve, however it is  
so rare, it is often mistaken for an  
allergic reaction. Advances in supportive  
care and immunosuppression may prove  
helpful in the future treatments of  
SJS/TEN. 
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Firstly, the health care team must 
rule out an infectious cause for the 
symptoms. “Patients should be tested 
with serology tests (IgM and IgG) and 
PCR (to assess viral replication) for 
herpes simplex virus 1 and 2, varicella-
zoster virus, cytomegalovirus, Epstein-
Barr virus, human herpes virus 6 and 7, 
parvovirus and  M pneumonia.” 
(Ferrandiz-Pulido & Garcia-Patos, 2013, 
p. 1001) Acute inflammatory mediators 
such as fibrinogen and CRP must be 
monitored. (Dedric et al., 2012, p. 58)  
 
Additionally, “the severe sloughing of 
the epidermis will produce a positive 
Nikolsky’s sign; a diagnostic maneuver of 
applying lateral pressure of the surface 
of the epidermis and sloughing of the 
skin occurs.” However, “A definitive 
diagnosis is made by full-thickness 
epidermal necrosis on biopsy.” (Barrick 
& Macatuno, 2014, p. 1104) 
 
 
 
 
 
 
 
 
 
 
 
  Additionally, Tumor-Necrosis Factor-α 
(TNF-α), a cytokine that prompts cell 
apoptosis, has been found in the fluid 
collected from the fluid draining from the 
fissures and bullae associated with 
SJS/TEN. TNF-α is a recruiter for 
additional WBC’s to the area of 
inflammation, further exacerbating the 
immune response. TENS compromises 
over 30% of a patients Body Surface area, 
so this hypersensitivity reaction can easily 
become a systemic inflammatory problem.  
(Shih-Chi & Wen-Hung, 2014, p. 202) 
 
        All this amounts to a severe sloughing 
of the epidermis from the dermis, resulting 
in partial to full thickness skin loss. 
Isotonic fluid loss, similar to that with burn 
victims is observed, along with 
excruciating pain.  
 
        However, keratinocytes and epidermal 
cells are not simply found in the skin. They 
make up parts of the eye, Gastro-Intestinal 
tract, all mucus membranes, the 
genitourinary system, and the trachea-
bronchial tree. (Cooper, 2012, p. 54) 
 
Damage to these body parts result in: 
Eye: 
• Ocular discomfort, photophobia, 
conjunctivitis, inflammation of the 
lacrimal gland which is important for 
defense against microorganisms, 
infection, and permanent blindess. 
(Frizon et al., 2014, p. 56) 
GI Tract: 
• Mucositis (oral ulcerations), 
dysphagia, intestinal bleeding, and 
diarrhea which potentiates decreased 
absorption of nutrition necessary for 
healing. 
Lungs 
• Increased permeability of the 
tracheobronchial leads to interstitial 
edema and infiltrates, inhibiting the 
diffusion of carbon dioxide and 
oxygen, leading to additional acid-
base imbalance. Additionally, 
obstruction from shedding layers of 
epidermis from dermis in the airway 
can lead to obstruction and hypoxia. 
          (Cooper, 2012, p. 55) 
 
        Therefore, it is theorized that a severe 
hypersensitive immune response occurs in 
which keratinocytes are marked for 
apoptosis due to a genetic predisposition 
coupled with exposure to drug metabolites 
that are interpreted as immunogenic.  
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Diagnosis 
The main culprits of medication 
causes for SJS/TEN come from NSAIDS, 
anti-epileptics and antibiotics. (Pakran et 
al., 2013, p. 86) 
• Vancomycin-Hcl 
• Valproate 
• Allopurinol 
• Ibuprofen 
 
 
 
• Male 
 
• Age 20-30 
 
• Previously diagnosed malignant 
neoplasms, AIDS, lupus, and viral 
infections. (Knight et al., 2014, p. 2) 
 
• Genetic predisposition to skin 
reactions to specific medications. 
(Karkucak, et al., 2012, p. 301) 
 
 
 
Causes 
Case Continued: 
Day 10, 12:00pm: 72 hours after oral 
lesions first presented, the patient’s vital 
signs as follows: 
Temperature 101.8 degrees Fahrenheit 
HR 140, Atrial Fibrillation, RVR  
BP 80/30  
RR 35  
SpO2 92%  
Lactic Acid 3.0 mmol/L 
WBC 28,000x109/L 
         Diagnosis of TEN made.      
         The serosanguinous fluid loss 
through pt’s fissures is so severe, she has 
now received 8L in NS boluses  since 
appearance of first oral blister.  
          Due to isotonic fluid loss, Levophed 
at 30mcg/min necessary to maintain a BP 
of 95/39. Neosynephrine drip started 
and BP rises to 101/60.  
           Pt is exhibited a marked decrease in 
urinary output, falling to less than 
20mL/hour due to her extreme fluid loss.   
 
 
 
 
 
 
 
 
 
 
        
 
 
        Pt’s kidneys experiencing damage as 
demonstrated by the Creatinine of 2.8 
mg/dL due to lack of perfusion to their 
tissues and epidermal cell apoptosis 
affecting the genitourinary system. Pt’s 
BUN 48 showing marked dehydration. 
        Upon Endotracheal suctioning, pink 
froth is emerging, suggestive of 
tracheobronchial damage. Pt’s acid base 
balance indicates uncompensated 
metabolic acidosis although hypoxemia is 
also present with a PaO2 of 66mmHg. 
This is probably due to her increased 
interstitial edema and atelecstasis caused 
by increased capillary permeability and 
weakness. Pt’s Positive End Expiratory 
pressure increased to 10. Pt paralyzed 
and sedated to increase ventilator 
compliance. 
         Pt now exhibited signs of GI bleeding 
with small amount of bright red blood 
emerging from anus. Scope not ordered 
at this time due to notion that it would 
cause further GI bleeding. 
 
                 
 
 
Case Resolution 
Physiology of Skin: 
The epidermis is the outermost layer 
of skin. Keratinocytes make up 90% of 
the cells found in the epidermis. They 
provide attachment the dermis and 
the epidermis.   
 
Underlying Pathophysiology:  
Recent studies have revealed a link 
between certain Human Leukocyte 
Antigen (HLA) alleles found on 
keratinocytes and SJS/TEN. This 
demonstrates a genetic 
predisposition.  
 
        The metabolites of certain 
medications or environmental 
exposures are recognized by T-cell 
receptors (TCR) on T-lymphocytes as 
immunogenic which causes the TCR to 
bind with the immunogen, causing the 
release of a cascade of cytotoxic T-
lymphocytes (CTL) and Natural Killer 
(NK) cells to lyse and destroy the 
keratinocyte. (Shih-Chi & Wen-Hung, 
2014, p. 195) 
        
 
 
 
 
 
 
 
 
 
        
 
      
        Once attached to the keratinocyte, 
Granulysin, a cytolytic protein 
released by CTLs and NK cells, works 
to destroy the keratinocyte by using 
its structure to cleave the 
mitochondria and lysosomes of the 
skin cell.  
 
      CTLs and NK also release perforin, 
another cytolytic protein, which forms 
pores in the cell wall of the skin cell to 
allow Granzyme B into the cell. 
Granzyme B induces DNA 
fragmentation by lysing the nucleus 
wall and dismantling keratinocyte 
DNA.  
 
        Additionally, Tumor-Necrosis 
Factor-α (TNF-α), a cytokine that 
prompts cell apoptosis, has been 
found in the fluid collected from the… 
 
 
Partial thickness sloughing of epidermis   
         Amiodarone IV started for A. 
Fib RVR. At this time the health care 
team cannot start Heparin because 
of suspected GI bleed.        
        Pt now has over 50% 
epidermal loss due to sloughing 
mostly over trunk, neck and face. 
Orders received to leave all 
adherent materials (patches, 
dressings) in place until further 
notice due to fear for more loss. Pt 
placed on air-fluidized bed and not 
to be turned. 
 
Resolution: Partially as a result of 
not being able to be turned, pt 
developed severe chronic PNA and 
required a tracheotomy. 
        The emergence of new blisters 
stopped around Day 15, but the 
hypersensitivie sloughing nature of 
the skin did not stop until about 
Day 40. Despite having an air-
fluidized bed made for burn victims 
designed to decrease bony 
prominence pressure, pt developed 
a sacral deep pressure ulcer, stage 
III that became infected.  
       Pt could not be on prophylactic 
Heparin due to compromised skin 
tissue and internal GI bleeds from 
necrosis of epithelial GI tissue. 
Subsequently, pt suffered a severe  
ischemic stroke in her Middle 
Cerebral Artery on day 28 of 
hospital admission due to an 
embolized clot from her A. Fib. Pt 
lost use of both legs, had increased 
weakness in her arms and 
expressive aphasia. She remained 
bedbound indefinitely. 
        After two months of hydrogel 
dressings to over 40% of the pt’s 
Body Surface Area, new areas of 
necrosis stopped forming.  
        Pt’s survived for one full year 
past her diagnosis, and her 
remaining few months included 
immobility complications such as 
UTI’s, bedsores, depression, and 
anxiety. Eventually, pt was made 
DNR-CC. Pt’s VS remained 
approximately as follows HR 80’s, 
BP 70/30, RR 35. She eventually 
passed due to left ventricular heart 
failure. 
 
 
 
 
 
 
        Nurses lie on the forefront of 
patient assessment. For diseases 
such as SJS/TEN, early 
identification of emerging signs 
and symptoms can save lives. 
Nurses must be especially vigilant 
about assessing a patients trunk 
and mouth, which are often zones 
neglected in non-critical care 
patients for concealment and 
privacy reasons. If a Nurse is 
charting “skin intact,” he or she has 
a responsibility to know the 
condition of the patients 
integumentary system. (Cooper, 
2012, p. 52) 
 
        Nurses also are heavily relied 
on to know all the medications 
prescribed, over-the-counter and 
herbal remedies a patient is taking. 
This is crucial for identifying a 
cause for SJS/TEN. There are 
between 100-200 drugs that 
possibly cause SJS/TEN. Also 
crucial is once identifying a 
causative agent, immediately 
discontinuing that medication. 
(Cooper, 2012, p. 53) 
 
        The most important factor in 
SJS/TEN treatment is time. The 
health care team needs to identify 
and remove the offending 
medication or environmental 
exposure quickly to limit damage 
to the body. SJS/TEN is often 
mistaken for a simple allergic 
reaction due to the rash 
commonality. However there are 
crucial and life-altering differences. 
Chiefly, the rash in SJS/TEN is 
painful and blisters, and 
respiratory symptoms are a late 
indication of disease in SJS/TEN 
where as in allergic reaction, 
respiratory reactions are early. 
(Cooper, 2012, p. 54) 
  
 
Risk Factors Keratinocytes connect 90% of the 
epidermal cells to the dermis. 
 
